Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 55150-330

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 55150-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Risk Estimates For Breast Cancer In Dmpa Users (Medroxyprogesterone Fig1)

This appears to be a table or figure showing odds ratios and confidence intervals related to the use of DMPA (a type of birth control) and increased risk for some outcome. The source of the data includes several studies conducted over the years.*

FDA Label Image

Chart (Medroxyprogesterone Fig2)

This appears to be a table or chart showing different methods of birth control and their effectiveness in preventing pregnancy. It includes options such as birth control pills, condoms, and sterilization, as well as natural methods such as monitoring fertility cycles and withdrawal. The numbers provided indicate the percentage of women who become pregnant while using each method.*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container Label)

This is a description of a medication with the NDC code 55150-329-01 which contains Medroxyprogesterone Acetate as active ingredient. It comes in the form of a Suspension for intramuscular use only, and is packaged in a single-dose vial of 1mL. The medication should be shaken vigorously before use and stored upright. The usual dosage is not specified and should be obtained from the accompanying prescribing information. The medication has been manufactured in India for AuroMedics Pharma LLC and is labeled with the code TSDRUGS/24/12015.*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container-Carton (1 Vial))

This appears to be a description of a medication called medroxyprogesterone acetate Injectable Suspension, USP, packaged in a 1mL Single-Dose Vial. The vials must be stored upright at a controlled room temperature and shaken vigorously before each use. The usual dosage is detailed in the accompanying prescribing information. Each milliliter contains medroxyprogesterone acetate USP, 150mg, as well as other ingredients like sodium chloride, polysorbate 80, and added preservatives. The vial stopper is not made with natural rubber latex. The medication is for intramuscular use only. Distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container-Carton (25 Vials))

FDA Label Image

Chemical Structure (Medroxyprogesterone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.